statins and glp 1 aggravate insulin resistance through reduced blood glucagon-like peptide-1 levels in a microbiota-dependent manner GLP-1 receptor agonists (GLP-1RAs): cardiovascular

QALY = quality-adjusted life year, ICER = incremental cost-effectiveness ratio, GLP-1 RAs = glucagon-like peptide-1 receptor agonists, BMI = body mass index, WTP = willingness-to-pay, ESG = endoscopic sleeve gastroplasty, NHS = National Health Service, MBS = metabolic/bariatric surgery

Reply STOP to opt out

When used under medical supervision, semaglutide GLP-1 can help reduce hunger, increase feelings of fullness, and support significant weight loss by decreasing calorie intake

The most common include: Nausea, especially in the first few weeks Decreased appetite Gastrointestinal discomfort Fatigue For someone in early recovery from alcohol, reduced appetite can be a real concern

Competing interests We have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper

Uh, it's really good at appetite suppression, less potent with weight loss compared to Ozempic Tirzepatide, which is Manjaro or Zep